A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : AR / androgen receptor

[Related PubMed/MEDLINE]
Total Number of Papers: 9558
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   AR  (>> Co-occurring Abbreviation)
Long Form:   androgen receptor
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A candidate androgen signalling signature predictive of response to abiraterone acetate in men with metastatic castration-resistant prostate cancer. AA, BMBs, CYP17, IHC, mCRPC
2020 A Multifunctional Therapy Approach for Cancer: Targeting Raf1- Mediated Inhibition of Cell Motility, Growth, and Interaction with the Microenvironment. ---
2020 A novel androgen receptor antagonist JJ-450 inhibits enzalutamide-resistant mutant ARF876L nuclear import and function. CRPC, GFP, WT
2020 A Novel Small Molecule Targets Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer. CRPC, IMTPPE
2020 A selective androgen receptor modulator SARM-2f activates androgen receptor, increases lean body mass, and suppresses blood lipid levels in cynomolgus monkeys. BW, LBM, TE
2020 Abnormal functions of Leydig cells in crossbred cattle-yak showing infertility. 3beta-HSD
2020 Acantholytic Squamous Cell Carcinoma and Salivary Duct Carcinoma Ex-pleomorphic Adenoma of the Submandibular Gland: A Report of Two Extremely Rare Cases with an Immunohistochemical Analysis. ASCC, CXPA, GCDFP, PA, SCC, SDC
2020 Activation of beta-Catenin Cooperates with Loss of Pten to Drive AR-Independent Castration-Resistant Prostate Cancer. ---
2020 Ameliorative effect of combined low dose of Pioglitazone and omega-3 on spermatogenesis and steroidogenesis in diabetic rats. 17beta-HSD, Bcl-2, ERalpha, GLUT3, MDA, NF-kB, PCNA, RT-PCR, SOD, T2DM, TZDs
10  2020 Analysis of AR-FL and AR-V1 in Whole Blood of Patients with Castration Resistant Prostate Cancer as a Tool for Predicting Response to Abiraterone Acetate. AA, CRPC
11  2020 Androgen and mineralocorticoid receptors are present on the germinal disc region in laying hens: Potential mediators of sex ratio adjustment in birds? GD, MR
12  2020 Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC). mCRPC, OS
13  2020 Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer. ADT, NEPC
14  2020 Androgen modulation of XBP1 is functionally driving part of the AR transcriptional program. UPR
15  2020 Androgen Receptor (AR)-TLR4 Crosstalk Mediates Gender Disparities in Hepatocellular Carcinoma Incidence and Progression. DHT, HCC
16  2020 Androgen Receptor and Its Splicing Variant 7 Expression in Peripheral Blood Mononuclear Cells and in Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer. AA, ARFL, CRPC, CTC, PBMC, PFS
17  2020 Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment. CRPC, PROTAC
18  2020 Androgen Receptor Expression in Adenoid Cystic Carcinoma of Breast: A Subset of Seven Cases. ACC
19  2020 Androgen Receptor Expression in Hypospadias. ---
20  2020 Androgen Receptor in Breast Cancer-Clinical and Preclinical Research Insights. BC, PC
21  2020 Androgen receptor reverses the oncometabolite R-2-hydroxyglutarate-induced prostate cancer cell invasion via suppressing the circRNA-51217/miRNA-646/TGFbeta1/p-Smad2/3 signaling. IDH1, PCa, R-2HG
22  2020 Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p/SLPI-mediated vasculogenic mimicry formation. AREs, BCa, LC-MS, PCa, VM
23  2020 Androgen receptor with short polyglutamine tract preferably enhances Wnt/beta-catenin-mediated prostatic tumorigenesis. ---
24  2020 Androgen receptor, aromatase, oestrogen receptor alpha/beta and G protein-coupled receptor 30 expression in the testes and epididymides of adult sheep. GPR30
25  2020 Androgen receptor-binding sites are highly mutated in prostate cancer. ---
26  2020 Androgen receptor-regulated circFNTA activates KRAS signaling to promote bladder cancer invasion. BCa, circFNTA, circRNAs
27  2020 Androgen receptor-related micro RNAs in prostate cancer and their role in antiandrogen drug resistance. miRNAs, PCa
28  2020 Androgen Receptor: Evaluation and Correlation with Recurrence and Clinicopathological Parameters in Papillary Urothelial Carcinomas of the Urinary Bladder. IHC, PUC
29  2020 Androgen-induced expression of DRP1 regulates mitochondrial metabolic reprogramming in prostate cancer. Drp1, PCa
30  2020 Anti-androgenic effect of 6-formylindolo[3,2-b]carbazole (FICZ) in LNCaP cells is mediated by the aryl hydrocarbon-androgen receptors cross-talk. DHT, FICZ, FLU, PSA
31  2020 AR mRNA stability is increased with AR-antagonist resistance via 3'UTR variants. ---
32  2020 AR pathway activity correlates with AR expression in a HER2-dependent manner and serves as a better prognostic factor in breast cancer. BC, PR
33  2020 AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-Mediated redox homeostasis. DHEA, GPx, ROS, TMZ
34  2020 AR-induced ZEB1-AS1 represents poor prognosis in cholangiocarcinoma and facilitates tumor stemness, proliferation and invasion through mediating miR-133b/HOXB8. CCA, HOXB8, ZEB1-AS1
35  2020 Arctigenin inhibits prostate tumor growth in high-fat diet fed mice through dual actions on adipose tissue and tumor. FFAs, HF
36  2020 Attenuation of benign prostatic hyperplasia by hydrophilic active compounds from pigmented rice in a testosterone implanted rat model. BPH, HIF, PCNA
37  2020 Bardoxolone-Methyl (CDDO-Me) Suppresses Androgen Receptor and Its Splice-Variant AR-V7 and Enhances Efficacy of Enzalutamide in Prostate Cancer Cells. ADT, CRPC, ENZ, NAC, PC, ROS
38  2020 BCOR-coupled H2A monoubiquitination represses a subset of androgen receptor target genes regulating prostate cancer proliferation. CRPC, ncPRC1.1
39  2020 Bicalutamide plus Aromatase Inhibitor in Patients with Estrogen Receptor-Positive/Androgen Receptor-Positive Advanced Breast Cancer. AI, CBR, ER, ORR, PFS
40  2020 Biomarkers of response to advanced prostate cancer therapy. PCa
41  2020 BMI1 is directly regulated by androgen receptor to promote castration-resistance in prostate cancer. BMI1, CRPC, DHT, EMT, PCa
42  2020 Characteristics, behaviour and role of biomarkers in metastatic triple-negative breast cancer. ERbeta, OS, TNBC
43  2020 Charge density view on bicalutamide molecular interactions in the monoclinic polymorph and androgen receptor binding pocket. ---
44  2020 Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer. cfDNA, CRPC-NE
45  2020 CMKLR1 deficiency attenuates androgen-inducedlipid accumulation in mice. BAT, CMKLR1, DHT, pERK, WAT
46  2020 Comparison of the clinicopathological features of pancreatic solid pseudopapillary neoplasms between males and females: gender does matter. SPN, SYN
47  2020 Comparison of the roles of estrogens and androgens in breast cancer and prostate cancer. BC, PC
48  2020 Deep androgen receptor suppression in prostate cancer exploits sexually dimorphic renal expression for systemic glucocorticoid exposure. CRPC
49  2020 Design, synthesis and characterization of a PEGylated stanozolol for potential therapeutic applications. 5 alpha-DHT, AAS, AChE, STZ
50  2020 DHT and E2 synthesis-related proteins and receptors expression in male yak skin during different hair follicle stages. DHT, HF
51  2020 Discovery of drugs that directly target the intrinsically disordered region of the androgen receptor. IDPs, LBD, NTD
52  2020 Diverse AR Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate Cancer. AR-V, CRPC
53  2020 Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived Xenografts. CRPC, DDR, ENZ, PDX, PSA, SPT
54  2020 Echinacoside‑induced nitric oxide production in endothelialcells: Roles of androgen receptor and the PI3K‑Akt pathway. ECH, eNOS, HUVECs, NO, PI3K
55  2020 Effect of aberrantly methylated androgen receptor target gene PCDH7 on the development of androgen-independent prostate cancer cells. AIPC
56  2020 Effects of aging on testosterone and androgen receptors in the mesocorticolimbic system of male rats. mPFC, NAc, OFC, VTA
57  2020 Elevated levels of tumor apolipoprotein-D independently predict poor outcome in breast cancer patients. ApoD, DFS, ERalpha, MFS, OS, VIA
58  2020 Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients. AEs, ALP, bmCRPC, CI, DDIs, mCRPC, PFS, PSA
59  2020 Enzalutamide-Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 Inhibitors. CRPC
60  2020 Evaluation of 17beta-hydroxysteroid dehydrogenase activity using androgen receptor-mediated transactivation. 17beta-HSDs, 46,XY DSD, HSD17B3
61  2020 Evaluation of the genomic alterations in the androgen receptor gene during treatment with high-dose testosterone for metastatic castrate-resistant prostate cancer. CRPC, ctDNA, HDT, TPP
62  2020 Evolution of the androgen receptor: Perspectives from human health to dancing birds. ---
63  2020 Formation of 5alpha-dihydrotestosterone from 5alpha-androstane-3alpha,17beta-diol in prostate cancer LAPC-4 cells - Identifying inhibitors of non-classical pathways producing the most potent androgen. 3alpha-diol, 5 alpha-DHT, PC
64  2020 FOXO1 as a tumor suppressor inactivated via AR/ERbeta signals in urothelial cells. ERbeta, p-FOXO1
65  2020 GRK2 enforces androgen receptor dependence in the prostate and prostate tumors. GRK2-DN
66  2020 Hexane Insoluble Fraction from Purple Rice Extract Retards Carcinogenesis and Castration-Resistant Cancer Growth of Prostate Through Suppression of Androgen Receptor Mediated Cell Proliferation and Metabolism. CRPC, TRAP
67  2020 High-dose nitrate therapy recovers the expression of subtypes alpha1 and beta-adrenoceptors and Ang II receptors of the renal cortex in rats with myocardial infarction-induced heart failures. ATR, CHF, PRA
68  2020 Hormonal and Molecular Regulation of Phallus Differentiation in a Marsupial Tammar Wallaby. ESR1, IGF1, IGFBP-3, lncRNAs, SHH
69  2020 Identification of retinoid acid induced 16 as a novel androgen receptor target in prostate cancer cells. ChIP, HCC, RAI16
70  2020 IL8 Expression Is Associated with Prostate Cancer Aggressiveness and Androgen Receptor Loss in Primary and Metastatic Prostate Cancer. PDX
71  2020 Imidacloprid disrupts the endocrine system by interacting with androgen receptor in male mice. IMI
72  2020 Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer. ---
73  2020 Increased androgen receptor levels and signaling in ovarian cancer cells by VEPH1 associated with suppression of SMAD3 and AKT activation. DHT, p-AKT, VEPH1
74  2020 Increased mediator complex subunit CDK19 expression associates with aggressive prostate cancer. DFS, IHC, PCa
75  2020 Influence of alpha-adrenoceptor antagonists therapy on stool form in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. BSFS, GSRS, IPSS, LUTS/BPH, QOL
76  2020 Inhibition of base excision repair by natamycin suppresses prostate cancer cell proliferation. BER, LIG I, PCa, pol beta
77  2020 Inhibition of noncanonical Wnt pathway overcomes enzalutamide resistance in castration-resistant prostate cancer. CRPC, PCa
78  2020 Inhibitory Interplay of SULT2B1b Sulfotransferase with AKR1C3 Aldo-keto Reductase in Prostate Cancer. AKR, CRPC, DHEA, DHT, EMT, GS, KO
79  2020 Intraductal Carcinoma of Salivary Glands Harboring TRIM27-RET Fusion with Mixed Low Grade and Apocrine Types. IDCs
80  2020 Levels of sex steroid hormones and their receptors in women with preeclampsia. DHEAS, ERalpha, PR
81  2020 Lipotoxicity Impairs Granulosa Cell Function Through Activated Endoplasmic Reticulum Stress Pathway. CYP19A1, GRP78, Hsd17b1, IRS-1
82  2020 LncNONO-AS regulates AR expression by mediating NONO. NONO
83  2020 Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor Cells. CTCs, EMT, TIMP1, TNBC
84  2020 Loss of androgen signaling in mesenchymal sonic hedgehog responsive cells diminishes prostate development, growth, and regeneration. SHH, TGF-beta1, UGE, UGM
85  2020 Male breast cancer: clinicopathological characterization of a National Danish cohort 1980-2009. ER, MBCP, OS, PgR, SMR
86  2020 May agricultural water sources containing mixtures of agrochemicals cause hormonal disturbances? ---
87  2020 Metabolomic Analysis of Morus Cultivar Root Extracts and Their Ameliorative Effect on Testosterone-Induced Prostate Enlargement in Sprague-Dawley Rats. BPH, ESI, MAPK, MRs, PLS-DA, PSA, UPLC-Q-TOF-MS
88  2020 Metabolomic profiling to evaluate the efficacy of proxalutamide, a novel androgen receptor antagonist, in prostate cancer cells. PCa
89  2020 MiR-133a-5p inhibits androgen receptor (AR)-induced proliferation in prostate cancer cells via targeting FUsed in Sarcoma (FUS) and AR. FUS, KMplot
90  2020 Molecular modelling methods in food safety: Bisphenols as case study. BPA, EU, FCMs, NRs, SVHC
91  2020 MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer. CRPC, NEPC
92  2020 Nandrolone decanoate and resistance exercise affect prostate morphology and hormone receptor interface in adult rats with implications for the aging process. ERs, ND, RE, VP
93  2020 Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets. PCa, PCSCs
94  2020 Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: Correlation between Androgen Receptor Expression and Pathological Response. NAC, pCR, QNBC, TNBC
95  2020 New Insights into the Binding Mechanism of Co-regulator BUD31 to AR AF2 Site: Structural Determination and Analysis of the Mutation Effect. LBD, MM-PBSA
96  2020 New insights into the expression of androgen and estrogen receptors of the appendix testis in congenital cryptorchidism. AT, ER, UC
97  2020 Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: analysis from the phase 2 TRITON2 study. DDR, mCRPC, PSA
98  2020 Novel approach to therapeutic targeting of castration-resistant prostate cancer. CRPC, EZH2
99  2020 Nuclear receptors are the major targets of endocrine disrupting chemicals. CAR, EDCs, ERalpha and ERbeta, ERRgamma, FXR, GR, MR, PR, PXR, TRalpha and TRbeta
100  2020 Ovarian Metabolic activity in Dehydroepiandrosterone-Induced Polycystic Ovary in Wistar rats Treated with Aspirin. DHEA, GST, PCOS, SOD